Twitter Facebook LinkedIn YouTube

New Listing: Nanalysis Scientific Corp. (TSXV:NSCI)

Video Platform Video Management Video Solutions Video Player

Formed in 2019, the company has a 10 year history as a global developer and supplier of portable nuclear Magnetic Resonance (NMR) spectrometers for the laboratory instrumentation market.

Additional Information:

Company: Nanalysis Scientific Corp.
Website: http://www.nanalysis.com
Stock Symbol: TSXV: NSCI
Date Published: Jun 13, 2019
Transcript: Available

Video Transcript:

I’m Megan Edwards for Investmentpitch Media

Nanalysis Scientific Corp. is one of the latest new listings on the TSX Venture Exchange, following its Qualifying Transaction with Canvass Ventures, a Capital Pool Company.

Formed in 2019, the company has a 10 year history as a global developer and supplier of portable nuclear Magnetic Resonance (NMR) spectrometers for the laboratory instrumentation market

The company has been awarded the prestigious Frost & Sullivan award in 2016 and 2018 as the Company of the Year in the Global Portable NMR sector.

The company sells direct in the United States, Canada, and Germany, and through local distributors in countries such as UK, Japan, India, and roughly 40 territories, where its products are used by various industries, such as oil & gas, chemical, pharma, biotech, food science, and atomic agencies.

Sean Krakiwsky, CEO of Nanalysis Scientific, stated: "We are very pleased to close the qualifying transaction with Canvass Ventures Ltd. This transaction gives us the capital and the public company currency to execute our global expansion strategy, which includes solid organic growth as well as acquisitions of complementary companies in the laboratory instrumentation space. After 10 years with a strong focus on our technology platform and manufacturing capabilities, and a solid revenue base, it is the right time to fuel global growth of our sales organization, and to build a fully vertically integrated global lab instrumentation company, with our proprietary magnetic resonance analyzers as our flagship product family. Management is excited about the milestones we are targeting in 2019, and we are focused on creating shareholder value in the short, medium, and long term."

The company recently raised approximately $5 million from a non-brokered private placement of 8,333,000 units priced at $0.60 per unit.

Each unit consisted of 1 share and one-half a warrant, with each full warrant exercisable at $0.75 for 12 months.

Subsequently, the company announced the closing of an additional non-brokered private placement of $1,500,000 from the sale of 2,500,000 units to the Chairman of Factors Group.

Based in Coquitlam, British Columbia, Factors Group has been a producer of the highest quality Natural Health Products and dietary supplements for more than 50 years.

The Chairman of Factors Group stated "We are very pleased we are investing in Nanalysis Scientific. Factors Group is committed to producing the highest quality products possible and seeing worldwide improvement of testing in all areas of product quality. The bench-top NMR technology that Nanalysis produces will provide our company with an invaluable tool to confirm source botanical identity and to monitor key active concentrations as products move through the production system and indeed is distributed to our customers, ensuring highest possible safety, potency, purity, and quality. We will be working with Nanalysis and other partners to develop software and reference standard databases that will assist regulatory authorities make progress with their mandates of ensuring nutraceutical authentication, and we will be promoting Nanalysis' products throughout our global network."

The shares are trading at $0.59.

For more information, please visit the company’s website www.nanalysis.com, or contact Sean Krakiwsky, President and CEO, at 587-899-0513, or email IR@nanalysis.com.

I’m Megan Edwards for Investmentpitch Media